CoChat

Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease

Open access
Baek, Judy, He, Chenchen, Afshinnia, Farsad, Michailidis, George, Pennathur, Subramaniam · 2022 · Nature Reviews Nephrology
Cited by 162

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Dyslipidaemia is a hallmark of chronic kidney disease (CKD). The severity of dyslipidaemia not only correlates with CKD stage but is also associated with CKD-associated cardiovascular disease and mortality. Understanding how lipids are dysregulated in CKD is, however, challenging owing to the incredible diversity of lipid structures. CKD-associated dyslipidaemia occurs as a consequence of complex interactions between genetic, environmental and kidney-specific factors, which to understand, requires an appreciation of perturbations in the underlying network of genes, proteins and lipids. Modern lipidomic technologies attempt to systematically identify and quantify lipid species from biological systems. The rapid development of a variety of analytical platforms based on mass spectrometry has enabled the identification of complex lipids at great precision and depth. Insights from lipidomics studies to date suggest that the overall architecture of free fatty acid partitioning between fatty acid oxidation and complex lipid fatty acid composition is an important driver of CKD progression. Available evidence suggests that CKD progression is associated with metabolic inflexibility, reflecting a diminished capacity to utilize free fatty acids through β-oxidation, and resulting in the diversion of accumulating fatty acids to complex lipids such as triglycerides. This effect is reversed with interventions that improve kidney health, suggesting that targeting of lipid abnormalities could be beneficial in preventing CKD progression. Dyslipidaemia is a hallmark of chronic kidney disease (CKD), with insights from lipidomics studies suggesting that alterations in free fatty acid partitioning may contribute to CKD progression. This Review provides an introduction to lipidomics and discusses insights from lipidomics studies of relevance to CKD. Lipidomic analyses remain a challenge due to the numerous species that exist within each class; techniques that reduce analytical complexity while retaining important information about lipid structure are useful for elucidating biological significance from lipidomics studies. The immense structural diversity of lipids means that lipidomic analyses are guided by a choice of untargeted and targeted analysis; sample preparation, extraction and separation methods may require optimization for specific classes of interest. A key challenge with profiling technologies such as lipidomics is the ability to use the data to gain insights into biological processes, including mechanisms of disease onset and progression Fatty acid profiles that are enriched in shorter and more saturated species are associated with later stages of chronic kidney disease (CKD) and are predictive of CKD progression. Acylcarnitine profiles provide insights into mitochondrial function; a lower ratio of long-chain to medium-chain acylcarnitines is indicative of increased mitochondrial inefficiency and is associated with worsening CKD. Patients with CKD or kidney failure demonstrate enrichment of complex lipids, such as triacylglycerols and phosphatidylethanolamines, with enrichment of longer and more unsaturated fatty acyl side-chains; an inverse association between mitochondrial efficiency and these complex lipids suggests a mechanistic link between fatty acid oxidation and fatty acid profiles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41581-021-00488-2

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Metadata

Authors
Baek, J., He, C., Afshinnia, F., Michailidis, G., & Pennathur, S.
Venue
Nature Reviews Nephrology
Published
2021-10-06
Volume
18
Issue
1
Pages
38-55
ISSN
  • 1745-8323 (ISSN-L)
  • 1759-5061
  • 1759-507X
OpenAlex
W3203319955
Cited by
162
References
21
FWCI
2.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease. https://app.cochat.ai/papers/10.1038/s41581-021-00488-2
The paper
Baek, J., He, C., Afshinnia, F., Michailidis, G., & Pennathur, S. (2022). Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease. Nature Reviews Nephrology. https://doi.org/10.1038/s41581-021-00488-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.